Literature DB >> 15981999

Structural consequences of the inhibitor-resistant Ser130Gly substitution in TEM beta-lactamase.

Veena L Thomas1, Dasantila Golemi-Kotra, Choonkeun Kim, Sergei B Vakulenko, Shahriar Mobashery, Brian K Shoichet.   

Abstract

Beta-lactamase confers resistance to penicillin-like antibiotics by hydrolyzing their beta-lactam bond. To combat these enzymes, inhibitors covalently cross-linking the hydrolytic Ser70 to Ser130 were introduced. In turn, mutant beta-lactamases have emerged with decreased susceptibility to these mechanism-based inhibitors. Substituting Ser130 with glycine in the inhibitor-resistant TEM (IRT) mutant TEM-76 (S130G) prevents the irreversible cross-linking step. Since the completely conserved Ser130 is thought to transfer a proton important for catalysis, its substitution might be hypothesized to result in a nonfunctional enzyme; this is clearly not the case. To investigate how TEM-76 remains active, its structure was determined by X-ray crystallography to 1.40 A resolution. A new water molecule (Wat1023) is observed in the active site, with two configurations located 1.1 and 1.3 A from the missing Ser130 Ogamma; this water molecule likely replaces the Ser130 side-chain hydroxyl in substrate hydrolysis. Intriguingly, this same water molecule is seen in the IRT TEM-32 (M69I/M182T), where Ser130 has moved significantly. TEM-76 shares other structural similarities with various IRTs; like TEM-30 (R244S) and TEM-84 (N276D), the water molecule activating clavulanate for cross-linking (Wat1614) is disordered (in TEM-30 it is actually absent). As expected, TEM-76 has decreased kinetic activity, likely due to the replacement of the Ser130 side-chain hydroxyl with a water molecule. In contrast to the recently determined structure of the S130G mutant in the related SHV-1 beta-lactamase, in TEM-76 the key hydrolytic water (Wat1561) is still present. The conservation of similar accommodations among IRT mutants suggests that resistance arises from common mechanisms, despite the disparate locations of the various substitutions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15981999      PMCID: PMC1382196          DOI: 10.1021/bi0502700

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  33 in total

Review 1.  How beta-lactamases have driven pharmaceutical drug discovery. From mechanistic knowledge to clinical circumvention.

Authors:  K Bush; S Mobashery
Journal:  Adv Exp Med Biol       Date:  1998       Impact factor: 2.622

2.  Structure of the SHV-1 beta-lactamase.

Authors:  A P Kuzin; M Nukaga; Y Nukaga; A M Hujer; R A Bonomo; J R Knox
Journal:  Biochemistry       Date:  1999-05-04       Impact factor: 3.162

3.  Mutant TEM beta-lactamase producing resistance to ceftazidime, ampicillins, and beta-lactamase inhibitors.

Authors:  Sergei Vakulenko; Dasantila Golemi
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

Review 4.  Inhibitor-resistant TEM beta-lactamases: phenotypic, genetic and biochemical characteristics.

Authors:  E B Chaïbi; D Sirot; G Paul; R Labia
Journal:  J Antimicrob Chemother       Date:  1999-04       Impact factor: 5.790

5.  Mechanism of inhibition of the class A beta -lactamases PC1 and TEM-1 by tazobactam. Observation of reaction products by electrospray ionization mass spectrometry.

Authors:  Y Yang; K Janota; K Tabei; N Huang; M M Siegel; Y I Lin; B A Rasmussen; D M Shlaes
Journal:  J Biol Chem       Date:  2000-09-01       Impact factor: 5.157

6.  Inhibition of the SHV-1 beta-lactamase by sulfones: crystallographic observation of two reaction intermediates with tazobactam.

Authors:  A P Kuzin; M Nukaga; Y Nukaga; A Hujer; R A Bonomo; J R Knox
Journal:  Biochemistry       Date:  2001-02-13       Impact factor: 3.162

7.  X-ray structure of the Asn276Asp variant of the Escherichia coli TEM-1 beta-lactamase: direct observation of electrostatic modulation in resistance to inactivation by clavulanic acid.

Authors:  P Swarén; D Golemi; S Cabantous; A Bulychev; L Maveyraud; S Mobashery; J P Samama
Journal:  Biochemistry       Date:  1999-07-27       Impact factor: 3.162

8.  An ultrahigh resolution structure of TEM-1 beta-lactamase suggests a role for Glu166 as the general base in acylation.

Authors:  George Minasov; Xiaojun Wang; Brian K Shoichet
Journal:  J Am Chem Soc       Date:  2002-05-15       Impact factor: 15.419

9.  Noncovalent interaction energies in covalent complexes: TEM-1 beta-lactamase and beta-lactams.

Authors:  Xiaojun Wang; George Minasov; Brian K Shoichet
Journal:  Proteins       Date:  2002-04-01

10.  Protonation of the beta-lactam nitrogen is the trigger event in the catalytic action of class A beta-lactamases.

Authors:  B P Atanasov; D Mustafi; M W Makinen
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

View more
  31 in total

1.  The acylation mechanism of CTX-M beta-lactamase at 0.88 a resolution.

Authors:  Yu Chen; Richard Bonnet; Brian K Shoichet
Journal:  J Am Chem Soc       Date:  2007-04-05       Impact factor: 15.419

2.  Variants of β-lactamase KPC-2 that are resistant to inhibition by avibactam.

Authors:  Krisztina M Papp-Wallace; Marisa L Winkler; Magdalena A Taracila; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2015-02-09       Impact factor: 5.191

3.  Saturation mutagenesis of Asn152 reveals a substrate selectivity switch in P99 cephalosporinase.

Authors:  Scott T Lefurgy; René M de Jong; Virginia W Cornish
Journal:  Protein Sci       Date:  2007-12       Impact factor: 6.725

4.  Avibactam and inhibitor-resistant SHV β-lactamases.

Authors:  Marisa L Winkler; Krisztina M Papp-Wallace; Magdalena A Taracila; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2015-02-17       Impact factor: 5.191

5.  Pareto Optimization of Combinatorial Mutagenesis Libraries.

Authors:  Deeptak Verma; Gevorg Grigoryan; Chris Bailey-Kellogg
Journal:  IEEE/ACM Trans Comput Biol Bioinform       Date:  2018-07-23       Impact factor: 3.710

6.  β-Lactamase inhibition by 7-alkylidenecephalosporin sulfones: allylic transposition and formation of an unprecedented stabilized acyl-enzyme.

Authors:  Elizabeth A Rodkey; David C McLeod; Christopher R Bethel; Kerri M Smith; Yan Xu; Weirui Chai; Tao Che; Paul R Carey; Robert A Bonomo; Focco van den Akker; John D Buynak
Journal:  J Am Chem Soc       Date:  2013-12-03       Impact factor: 15.419

7.  Combinatorial active-site variants confer sustained clavulanate resistance in BlaC β-lactamase from Mycobacterium tuberculosis.

Authors:  Philippe Egesborg; Hélène Carlettini; Jordan P Volpato; Nicolas Doucet
Journal:  Protein Sci       Date:  2014-12-30       Impact factor: 6.725

8.  An antibiotic-resistance enzyme from a deep-sea bacterium.

Authors:  Marta Toth; Clyde Smith; Hilary Frase; Shahriar Mobashery; Sergei Vakulenko
Journal:  J Am Chem Soc       Date:  2010-01-20       Impact factor: 15.419

9.  Characterization of the global stabilizing substitution A77V and its role in the evolution of CTX-M β-lactamases.

Authors:  Meha P Patel; Bartlomiej G Fryszczyn; Timothy Palzkill
Journal:  Antimicrob Agents Chemother       Date:  2015-08-17       Impact factor: 5.191

10.  Genetic and structural characterization of an L201P global suppressor substitution in TEM-1 beta-lactamase.

Authors:  David C Marciano; Jeanine M Pennington; Xiaohu Wang; Jian Wang; Yu Chen; Veena L Thomas; Brian K Shoichet; Timothy Palzkill
Journal:  J Mol Biol       Date:  2008-09-16       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.